| 查看: 1983 | 回复: 0 | ||
| 【悬赏金币】回答本帖问题，作者LYLQJ将赠送您 20 个金币 | ||
[求助]
求助如何更新已在genbank提交的序列的注释
|
||
|
各位大佬，如题，新手小白，想更新已提交至GenBank的序列(未公开)的注释。我是在blankt上提交的序列，我按照NCBI上的步骤(https://www.ncbi.nlm.nih.gov/genbank/update/)，请求他们发送一个包含当前注释的 5 列表格(feature_table.txt)，并在对该文件进行更新后回信发送给GenBank。不知道什么原因，过了一周没收到回信，于是我写了一份问询信，并在第二天收到GenBank的回信“The update you requested will be incorporated when your record is processed”。我想请问一下我这是更新成功了，要是没成功该怎么操作更新呢？网络上寻找了半天没有找到解答。 不知为什么上传不了图片 1. Dear GenBank Submissions Staff , Hope you are well after receiving this message. I am writing to request an update to my previously submitted sequence, with accession number PVxxxxxx, submitted via BankIt on January 31, 2025. The following changes are required: Annotation updates: Add missing tRNA-Lys gene. Add missing tRNA-Cys gene. Add missing tRNA-Arg gene. Add missing tRNA-Ala gene. Change the annotation information for tRNA-Phe and tRNA-Ser2. I've added two attachments, and Attachment 2 (updated.txt) shows which genes I updated. Annex 2(feature_table.txt) is shown as a full note. If there is a file upload error or the upload format is not standardized, please let me know as soon as possible, and I will correct it and return it immediately Thanks for your help. Best regards, Dr. Lin 2. Dear Colleague, Regarding your inquiry: Since I have not received your reply, I am writing to confirm whether you have received my reply. If you have not received my reply, please let me know and I will resubmit it. If you have received it, is there any problem with the previously submitted update? Is there any problem with the content or arrangement format of the submitted file? Please let me know. Should I resubmit the application serial number on Genbank? ============================================================================ ============================================================================ The update you requested will be incorporated when your record is processed. Please contact us if you wish to discuss the status of your record at any time. Please reply using the current Subject line. Sincerely, GBC-500 1 Contractor The GenBank Submissions Staff Bethesda, Maryland USA ******************************************************************* gb-admin@ncbi.nlm.nih.gov (for replies/updates to records in GenBank) info@ncbi.nlm.nih.gov (for general questions regarding GenBank) ******************************************************************* |
回复此楼» 猜你喜欢
WRN变构抑制剂HRO761：从D1/D2界面锁定到MSI合成致死的工具化合物深度解析
已经有0人回复
-
KRAS G12V(ON) 选择性抑制剂 RMC-5127：从三元复合物机制到科研应用
已经有0人回复
-
化学工程及工业化学论文润色/翻译怎么收费?
已经有161人回复
-
SHP2 变构抑制剂 Sitneprotafib：从作用机制到科研试剂选型要点
已经有0人回复
-
PRMT5·MTA 抑制剂 MRTX1719 的科研应用
已经有0人回复
-
SW033291 科研使用解析：分子特征、储存与实验获取要点
已经有0人回复
-
泛 RAS 抑制新思路：大环肽拟似物如何同时牵住突变型与野生型 RAS？
已经有0人回复
-
TYK2/JAK1 双靶点工具化合物 Brepocitinib：激酶选择性、研究进展与实验应用全解析
已经有0人回复
-
矢车菊素-3-O-葡萄糖苷质控实录：从一张HPLC图谱读懂纯度与稳定性
已经有0人回复
-
恩诺沙星（Enrofloxacin）科研解析：分子特征、LC-MS/MS 检测与实验室使用要点
已经有0人回复
-
Calderasib理化性质与实验操作技术笔记
已经有0人回复
